Form 4: Northrop Grumman Exec's Equity Changes

Sentiment:

Insider Transaction Report


Northrop Grumman's CVP & President of Mission Systems, Roshan S. Roeder, reported significant equity transactions, including the settlement of performance-based awards and new restricted stock grants.

Summary

  • Roshan S. Roeder, CVP & President of Mission Systems at Northrop Grumman Corp, reported changes in beneficial ownership of company stock.
  • Acquired 6,476.48 shares of common stock on February 11, 2026, through the exercise or conversion of derivative securities (Code M) at a price of $0.
  • Disposed of 2,968 shares of common stock on February 11, 2026, to cover tax withholding obligations (Code F) at a price of $678.83 per share.
  • Directly owns 3,912.39 shares of common stock following these transactions.
  • Indirectly owns 115.5111 shares of common stock held in the Northrop Grumman Savings Plan.
  • Acquired 5,786.48 Restricted Performance Stock Rights (RPSRs) on February 11, 2026, at a price of $0. These include 2,100.48 vested RPSRs from a 2023 grant (settled at 148% of target) and 3,686 unvested RPSRs from a 2024 grant.
  • Exercised/Matured 6,476.48 RPSRs on February 11, 2026, at a price of $0.
  • Acquired 1,701 Restricted Stock Rights (RSRs) on February 11, 2026, at a price of $0, which will vest on February 12, 2029.
  • Total beneficial ownership of derivative securities includes 20,650.48 RPSRs and 8,530 RSRs across various grants with different vesting/measurement periods.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a slightly positive routine filing, primarily due to the strong settlement of performance-based awards at 148% of target, indicating robust achievement of prior performance metrics.

Positives

  • Settlement of 2023 Restricted Performance Stock Rights (RPSRs) at 148% of the target award, indicating strong performance against the applicable metrics for the measurement period ended December 31, 2025.
  • Grant of new Restricted Performance Stock Rights (3,686 RPSRs) and Restricted Stock Rights (1,701 RSRs) under the 2024 Long-Term Incentive Stock Plan, aligning executive incentives with future company performance.

Negatives

  • Disposal of 2,968 shares of common stock at $678.83 per share, likely for tax withholding purposes upon the vesting of equity awards, which is a common practice but reduces direct ownership.

Future Outlook

Future equity awards, including 3,686 Restricted Performance Stock Rights (RPSRs) and 1,701 Restricted Stock Rights (RSRs), are scheduled to vest or have measurement periods ending between December 31, 2026, and February 12, 2029, aligning executive incentives with long-term company performance.

Industry Context

StockSavvy.ai notes that executive equity transactions, particularly those involving performance-based awards and tax-related share disposals, are standard practice in the defense and aerospace industry. These compensation structures are designed to align executive interests with long-term shareholder value creation, a common theme among peers like Lockheed Martin (LMT) and Raytheon Technologies (RTX).

Comparison to Industry Standards

  • Executive compensation structures involving Restricted Performance Stock Rights (RPSRs) and Restricted Stock Rights (RSRs) are consistent with practices observed at major defense contractors such as Lockheed Martin (LMT) and Raytheon Technologies (RTX).
  • The settlement of performance-based awards at 148% of target for the measurement period ending December 31, 2025, suggests strong operational or financial performance, which is a positive indicator when compared to general industry performance benchmarks.
  • The disposal of shares for tax withholding upon vesting is a routine and expected event in executive compensation across all industries, not specific to defense.

Stakeholder Impact

  • Shareholders: The settlement of performance-based awards at 148% of target suggests strong company performance, which is generally positive for shareholders. Executive compensation structures aim to align management incentives with shareholder value.
  • Employees: No direct impact mentioned, but executive compensation practices can influence overall company culture and morale.

Next Steps

  • Vesting of 2,017 RSRs on February 16, 2026.
  • End of measurement period for 5,133 RPSRs on December 31, 2026.
  • Vesting of 2,356 RSRs on February 16, 2027.
  • End of measurement period for 5,355 RPSRs on December 31, 2027.
  • Vesting of 2,456 RSRs on February 18, 2028.
  • End of measurement period for 3,686 RPSRs on December 31, 2028.
  • Vesting of 1,701 RSRs on February 12, 2029.

Key Dates

DateDescription
2023-02-16Grant date for RPSRs under 2011 LTISP, with measurement period ending 12/31/25, and RSRs under 2011 LTISP vesting 02/17/26.
2024-02-14Grant date for RPSRs under 2011 LTISP with measurement period ending 12/31/26, and RSRs under 2011 LTISP vesting 02/16/27.
2025-02-18Grant date for RPSRs under 2024 LTISP with measurement period ending 12/31/27, and RSRs under 2024 LTISP vesting 02/18/28.
2025-12-31End of measurement period for 2023 RPSRs, which settled at 148% of target.
2026-02-11Date of earliest transaction reported, including acquisition of common stock, disposal of common stock, acquisition of new RPSRs and RSRs, and settlement of prior RPSRs.
2026-02-13Signature date of the reporting person's attorney-in-fact.
2026-02-16Vesting date for 2,017 RSRs granted under the 2011 LTISP.
2026-12-31End of measurement period for 5,133 RPSRs granted under the 2011 LTISP on 02/14/24.
2027-02-16Vesting date for 2,356 RSRs granted under the 2011 LTISP.
2027-12-31End of measurement period for 5,355 RPSRs granted under the 2024 LTISP on 02/18/25.
2028-02-18Vesting date for 2,456 RSRs granted under the 2024 LTISP.
2028-12-31End of measurement period for 3,686 RPSRs granted under the 2024 LTISP on 02/11/26.
2029-02-12Vesting date for 1,701 RSRs granted under the 2024 LTISP on 02/11/26.

Recommendation

hold

This Form 4 details routine executive compensation transactions, including the vesting of performance-based awards and subsequent tax-related share disposals. It does not provide new fundamental information to alter the investment thesis for Northrop Grumman, thus a 'hold' recommendation is maintained. The strong performance award settlement is a positive indicator of past performance but is already reflected in the stock price.

Keywords

Northrop Grumman, NOC, SEC Form 4, Insider Trading, Executive Compensation, Restricted Stock Rights, Performance Stock Rights, Equity Awards, Stock Options, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.